Don't Buy Aurora Cannabis Stock Until These 3 Things Happen
Yesterday, Aurora Cannabis (NYSE: ACB) unveiled its fiscal 2020 second-quarter results. Even though the company performed terribly on nearly every financial metric possible for the three-month period, the company's stock still ended the day in positive territory.
Some investors, in short, seem to be convinced that the bottom has finally arrived. After all, Aurora's stock is down by a jaw-dropping 80% over the past 12 months, it is in the process of making major changes to the C-suite, and it recently announced a number of structural changes that should drastically reduce expenses from this point forward. Nonetheless, the worst may be yet to come. Here are three specific events that arguably need to take place before Aurora's shares can be considered a worthwhile long-term buy.
Image source: Getty Images.
Source Fool.com
